Market for antidepressants, anti-anxiolytics to decline
from Psychiatry Advisor
The global market for anxiety disorder and depression drugs is expected to modestly decline in the next five years, falling to about $18.2 billion in 2020, down from last year's total of $22.5 billion. In a new report, consulting group Transparency Market Research says that the global market for anxiety treatments and antidepressants will decline at a compound annual growth rate of 1.25 percent between 2014 and 2020.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063